title: Genital warts: current and future management options.
abstract: Genital warts are a cosmetic nuisance. They are caused by low-risk human papillomavirus types, have no oncogenic potential and are not linked to cervical cancer. However, they often cause significant psychological morbidity. Treatments are aimed at eradicating the unsightly lesions and stimulating the immune system to generate clearance and prevent recurrence. Commonly used physical treatment methods include cryotherapy, trichloroacetic acid, laser, and electrocautery. However, many patients respond extremely well to home therapies with either podophyllotoxin or imiquimod. Patients prefer the comfort and dignity of home treatment, and this should be the first-line of treatment for the majority of patients. A routine screen for sexually transmitted infections is appropriate in most cases. Detailed explanation and reassurance are of paramount importance in reducing the psychological distress associated with this unpleasant genital condition.
authors.affiliation: Department of Sexual Health, Countess of Chester Hospital NHS Foundation Trust, Chester, England. Colm.OMahony@coch.nhs.uk
authors.forename: Colm
authors.initials: C
authors.lastname: O'Mahony
mesh_terms: D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000465:Algorithms; D000634:Aminoquinolines / Q000627:therapeutic use; D002424:Caustics / Q000627:therapeutic use; D003218:Condylomata Acuminata / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy*; D017679:Cryotherapy; D006801:Humans; D000077271:Imiquimod; D007641:Keratolytic Agents / Q000627:therapeutic use; D011034:Podophyllotoxin / Q000627:therapeutic use; D012307:Risk Factors; D014238:Trichloroacetic Acid / Q000627:therapeutic use
chemical_list: D000276:Adjuvants, Immunologic; D000634:Aminoquinolines; D002424:Caustics; D007641:Keratolytic Agents; D014238:Trichloroacetic Acid; D011034:Podophyllotoxin; D000077271:Imiquimod